RYAN SATTAR: Open Payments
NPI 1871151753 · CLINTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 81 payments from 12 companies in 2025. Trend: 2023 $1,653 · 2024 $1,214 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 13 | $345 |
| GENZYME CORPORATION | 8 | $265 |
| GlaxoSmithKline, LLC. | 12 | $246 |
| Viatris Specialty LLC | 10 | $227 |
| Grifols USA, LLC | 8 | $204 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Regeneron Healthcare Solutions, Inc. | 8 | $148 |
| Insmed, Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
Products named: DUPIXENT, Ohtuvayre, YUPELRI, Prolastin-C Liquid, TEZSPIRE, Arikayce, NUCALA, GLASSIA.
Industry payments across SC — which companies pay providers there.
